Lv1
34 积分 2023-02-13 加入
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
4天前
已完结
Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors
17天前
已完结
Tumor biomarkers for diagnosis, prognosis and targeted therapy
17天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
1个月前
已完结
Acquired Resistance to KRASG12C Inhibition in Cancer
1个月前
已完结
The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?
1个月前
已完结
The pancreatic cancer drug market
4个月前
已关闭
Emerging landscape of KRAS inhibitors in cancer treatment
5个月前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
Targeting Modulated Vascular Smooth Muscle Cells in Atherosclerosis via FAP-Directed Immunotherapy
5个月前
已完结
皖公网安备34019202002308
